Literature DB >> 21741276

Long-term outcome of epilepsy in Kabuki syndrome.

Alberto Verrotti1, Sergio Agostinelli, Chiara Cirillo, Claudia D'Egidio, Angelika Mohn, Agata Boncimino, Giangennaro Coppola, Alberto Spalice, Francesco Nicita, Piero Pavone, Giuseppe Gobbi, Salvatore Grosso, Francesco Chiarelli, Salvatore Savasta.   

Abstract

UNLABELLED: PURPOSES AND METHODS: Kabuki syndrome (KS) is a rare dysmorphic disorder characterized by multiple congenital anomalies and mental retardation. Although epilepsy is one of the most common clinical complications associated with KS, few studies have evaluated its electroclinical aspects and long-term outcome. Therefore, we describe here a clinical series of 10 Caucasian KS patients who developed epilepsy in childhood. We followed all children for at least 5 years.
RESULTS: All patients presented partial seizures and interictal EEGs revealed focal epileptic paroxysms with prevalent involvement of temporo-occipital areas. Seven children had no central nervous system abnormalities, but enlargement of lateral ventricles, corpus callosum hypoplasia, and adenohypophysis hypoplasia were revealed in three. Although antiepileptic drug (AED) treatment was effective in controlling seizures and normalizing EEG abnormalities in 8 patients, the other 2 cases were resistant to multiple AEDs. In one of these two patients, withdrawal of AED resulted in status epilepticus and death.
CONCLUSIONS: Partial seizures and temporo-occipital abnormalities on interictal EEG are common features of KS patients who suffer from epilepsy. Prognosis of this epilepsy is favourable in the majority of cases with complete disappearance of seizures and EEG abnormalities.
Copyright © 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21741276     DOI: 10.1016/j.seizure.2011.06.005

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  4 in total

Review 1.  Kabuki syndrome: clinical and molecular characteristics.

Authors:  Chong-Kun Cheon; Jung Min Ko
Journal:  Korean J Pediatr       Date:  2015-09-21

2.  Exploring the cognitive phenotype of Kabuki (Niikawa-Kuroki) syndrome.

Authors:  L C M van Dongen; P A M Wingbermühle; W M van der Veld; C Stumpel; T Kleefstra; J I M Egger
Journal:  J Intellect Disabil Res       Date:  2019-02-06

3.  Inhibition of Notch signaling rescues cardiovascular development in Kabuki Syndrome.

Authors:  Maria de Los Angeles Serrano; Bradley L Demarest; Tarlynn Tone-Pah-Hote; Martin Tristani-Firouzi; H Joseph Yost
Journal:  PLoS Biol       Date:  2019-09-03       Impact factor: 8.029

Review 4.  Kabuki Syndrome-Clinical Review with Molecular Aspects.

Authors:  Snir Boniel; Krystyna Szymańska; Robert Śmigiel; Krzysztof Szczałuba
Journal:  Genes (Basel)       Date:  2021-03-25       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.